meine quelle: investorshub
CBIS ~NEWS>>Cannabis Science Inc. To Oversee Research For NewColombia Resources
May 21, 2014 (ACCESSWIRE via COMTEX) -- Cannabis Science Inc. (otcqb:CBIS) saw its share volume cut in half on May 20th with 5,662,881 shares exchanging hands compared to its three month daily average volume of 10,912,873 shares.
Just last week, it was announced that NewColombia Resources is in discussions with Cannabis Science, Inc. to oversee research in Colombia once protocols are established by Farmatech S.A., a pharmaceutical laboratory that collaborates with private companies, universities, NGOs, and institutions. Farmatech S.A.is in an agreement with New Colombia for the research and development of topical cannabis based medicines to treat skin cancer and other ailments in Colombia.
Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate.
The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers and neurological conditions. |